EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

EGFR Targeting of Liposomal Doxorubicin Improves Recognition and Suppression of Non-Small Cell Lung Cancer

Ernest Moles iD, David W Chang, Friederike M Mansfeld, Alastair Duly, Kathleen Kimpton, Amy Logan iD, Christopher B Howard, Kristofer J Thurecht iD, Maria Kavallaris iD

International Journal of Nanomedicine · 2024-04 · Volume 19 · 3623-3639

DOI: 10.2147/ijn.s450534 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024-04. Verfasst von Ernest Moles und 8 weiteren Autor:innen. Beteiligte Einrichtung: Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney, NSW, 2052, Australia. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Doxorubicin, ErbB Receptors, Lung Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungDoxorubicinErbB ReceptorsLung NeoplasmsAnimalsFemaleHumansMiceCell Line, TumorDrug Delivery SystemsMice, NudePolyethylene GlycolsTissue DistributionXenograft Model Antitumor Assays

Stichwörter der Autor:innen

EGFR targetingPEGylated liposomal doxorubicinbispecific antibodiesnon-small cell lung cancertargeted drug delivery

Substanzen

DoxorubicinEGFR protein, humanErbB Receptorsliposomal doxorubicinPolyethylene Glycols

Autor:innen und Institutionen

  • Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney, NSW, 2052, Australia.
  • UNSW Australian Centre for Nanomedicine, Faculty of Engineering, UNSW, Sydney, NSW, 2052, Australia.
  • School of Clinical Medicine, Faculty of Medicine & Health, UNSW, Sydney, NSW, 2052, Australia.
  • UNSW RNA Institute, Faculty of Science, UNSW, Sydney, NSW, 2052, Australia.
  • Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, St Lucia, QLD, 4072, Australia.
  • Centre for Advanced Imaging, ARC Training Centre for Innovation in Biomedical Imaging Technologies, University of Queensland, St Lucia, QLD, 4072, Australia.

ORCID-Profile: Ernest Moles, Amy Logan, Kristofer J Thurecht, Maria Kavallaris

Zitieren

APA

Moles, E., Chang, D. W., Mansfeld, F. M., Duly, A., Kimpton, K., Logan, A., Howard, C. B., Thurecht, K. J., & Kavallaris, M. (2024). EGFR Targeting of Liposomal Doxorubicin Improves Recognition and Suppression of Non-Small Cell Lung Cancer. International Journal of Nanomedicine, Volume 19, 3623-3639. https://doi.org/10.2147/ijn.s450534

Vancouver

Moles E, Chang DW, Mansfeld FM, Duly A, Kimpton K, Logan A, et al. EGFR Targeting of Liposomal Doxorubicin Improves Recognition and Suppression of Non-Small Cell Lung Cancer. International Journal of Nanomedicine. 2024;Volume 19:3623-3639. doi:10.2147/ijn.s450534

BibTeX
@article{Moles2024,
  author = {Moles, Ernest and Chang, David W and Mansfeld, Friederike M and Duly, Alastair and Kimpton, Kathleen and Logan, Amy and Howard, Christopher B and Thurecht, Kristofer J and Kavallaris, Maria},
  title = {EGFR Targeting of Liposomal Doxorubicin Improves Recognition and Suppression of Non-Small Cell Lung Cancer},
  journal = {International Journal of Nanomedicine},
  year = {2024},
  volume = {Volume 19},
  pages = {3623--3639},
  doi = {10.2147/ijn.s450534}
}
Kostenlos starten →